drugset / Trial / NCT01103518

Ethinyl Estradiol and Cyproterone Acetate in Irregular Menstruation

NCT01103518

Phase 4 Unknown 100 enrolled Fundação Educacional Serra dos Órgãos
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a Phase IV, randomized, double-blind, comparative study of the use of two preparations of ethinyl estradiol and cyproterone acetate in the treatment of menstrual irregularities of hyper-androgenic origin.

Timeline

Start
2009-12
Primary completion
2010-11
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Subject cyproterone acetate Small molecule 2 mg
Subject ethinyl estradiol Small molecule 0.035 mg

Indications